Validating Interventions for Diverse Adolescents (VIDA)

April 13, 2023 updated by: University of Utah

Efficacy of Group Treatment for Hispanic Adolescents - RCT

The purpose of this study is to compare a culturally adapted and a non-culturally adapted group-based substance abuse treatment with Latino adolescents.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Utah
      • Salt Lake City, Utah, United States, 84112
        • University of Utah

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adolescent between 13-18 years of age
  • Parental consent
  • Adolescent speaks English and Spanish
  • Adolescent assent to participate in treatment and assessments
  • Adolescent meets either DSM-IV diagnostic criteria for substance abuse or dependence
  • Adolescent identifies as Hispanic

Exclusion Criteria:

  • Adolescent younger than 13 or older than 18 years of age
  • Adolescent requires higher level of care than what is provided in study
  • Adolescent speaks only English or Spanish
  • Parental consent not obtainable
  • Adolescent does not assent to study
  • Adolescent is overtly psychotic, severely depressed/suicidal, and/or presents with other mental disorder that will limit participation in group treatment
  • Adolescent has completed substance abuse treatment elsewhere in the past 90 days
  • Adolescent does not identify as Hispanic

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Culturally Adapted Cognitive-Behavioral Treatment
Culturally Adapted CBT for Substance Abuse
Behavioral: Culturally Adapted Cognitive-Behavioral Treatment
Culturally Adapted CBT for Substance Abuse
Active Comparator: Standard Cognitive-Behavioral Treatment
Standard Cognitive-Behavioral Treatment for Substance Abuse
Behavioral: Standard Cognitive Behavioral Treatment
Standard CBT for Substance Abuse

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Substance Use Levels
Time Frame: Posttreatment, 3, 6, 12-month follow-ups
Posttreatment, 3, 6, 12-month follow-ups

Secondary Outcome Measures

Outcome Measure
Time Frame
Satisfaction with Treatment
Time Frame: Posttreatment
Posttreatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Utah

Collaborators

National Institute on Drug Abuse (NIDA)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2010

Primary Completion (Actual)

February 1, 2013

Study Completion (Actual)

February 1, 2013

Study Registration Dates

First Submitted

November 23, 2009

First Submitted That Met QC Criteria

November 23, 2009

First Posted (Estimate)

November 25, 2009

Study Record Updates

Last Update Posted (Actual)

April 18, 2023

Last Update Submitted That Met QC Criteria

April 13, 2023

Last Verified

April 1, 2013

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB_00041220
  • K23DA019914 (U.S. NIH Grant/Contract)
  • 5K23DA19914-5

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance-Related Disorders

Clinical Trials on Culturally Adapted Cognitive-Behavioral Treatment

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe